133 related articles for article (PubMed ID: 1652962)
1. Inhibition of bovine brain calmodulin-dependent cGMP phosphodiesterase by peptide and non-peptide angiotensin receptor ligands.
Sharma RK; Smith JR; Moore GJ
Biochem Biophys Res Commun; 1991 Aug; 179(1):85-9. PubMed ID: 1652962
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle.
Koziarz P; Beck J; Moore GJ
Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653
[TBL] [Abstract][Full Text] [Related]
3. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.
Scanlon MN; Moore GJ
Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047
[TBL] [Abstract][Full Text] [Related]
4. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
Lin K; Chan SH; Chan JY
Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
[TBL] [Abstract][Full Text] [Related]
5. Characterization of binding sites for the angiotensin II antagonist 125I-[Sarc1,Ile8]-angiotensin II on murine neuroblastoma N1E-115 cells.
Fluharty SJ; Reagan LP
J Neurochem; 1989 May; 52(5):1393-400. PubMed ID: 2709010
[TBL] [Abstract][Full Text] [Related]
6. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
Song K; Allen AM; Paxinos G; Mendelsohn FA
J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
[TBL] [Abstract][Full Text] [Related]
7. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta using a slowly dissociating antagonist [Sar1,Ile8]ANG II for receptor blockade.
Scanlon MN; Moore GJ
J Pharmacol Methods; 1988 Nov; 20(3):207-24. PubMed ID: 3236889
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of octa- and heptapeptide antagonists of angiotensin II as inhibitors of angiotensin III binding in the rat adrenal glomerulosa.
Douglas JG; Khosla MC; Bumpus FM
Endocrinology; 1985 Apr; 116(4):1598-602. PubMed ID: 3971929
[TBL] [Abstract][Full Text] [Related]
10. Pressor action and dipsogenicity induced by angiotensin II and III in rats.
Wright JW; Morseth SL; Abhold RH; Harding JW
Am J Physiol; 1985 Nov; 249(5 Pt 2):R514-21. PubMed ID: 4061676
[TBL] [Abstract][Full Text] [Related]
11. A non-radioactive method for angiotensin II receptor binding studies using the rat liver.
Akhavan MM; Ebrahimi SA; Mahmoudian M
J Pharmacol Toxicol Methods; 2006; 53(3):206-14. PubMed ID: 16165374
[TBL] [Abstract][Full Text] [Related]
12. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Wienen W; Mauz AB; Van Meel JC; Entzeroth M
Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
[TBL] [Abstract][Full Text] [Related]
13. The effects of peptide and nonpeptide angiotensin II-receptor ligands on the activity of brain monoamine oxidase in water-repleted rats.
Stancheva S; Alova L; Georgiev V
Acta Physiol Pharmacol Bulg; 2000; 25(2):51-6. PubMed ID: 11140171
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.
Krebs LT; Kramár EA; Hanesworth JM; Sardinia MF; Ball AE; Wright JW; Harding JW
Regul Pept; 1996 Dec; 67(2):123-30. PubMed ID: 8958583
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of action of sarmesin and sarilesin at angiotensin receptors in smooth muscle.
Koziarz P; Moore GJ
Proc West Pharmacol Soc; 1989; 32():79-84. PubMed ID: 2780619
[No Abstract] [Full Text] [Related]
16. Participation of angiotensin receptors in acute hypoxia in mice. I. Effects of angiotensin peptide receptor ligands saralasin and sarmesin.
Georgiev V; Opitz M
Methods Find Exp Clin Pharmacol; 1999; 21(6):415-9. PubMed ID: 10445234
[TBL] [Abstract][Full Text] [Related]
17. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
18. Obligatory Metabolism of Angiotensin II to Angiotensin III for Zona Glomerulosa Cell-Mediated Relaxations of Bovine Adrenal Cortical Arteries.
Kopf PG; Park SK; Herrnreiter A; Krause C; Roques BP; Campbell WB
Endocrinology; 2018 Jan; 159(1):238-247. PubMed ID: 29088382
[TBL] [Abstract][Full Text] [Related]
19. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
Moore GJ; Ganter RC; Goghari MH; Franklin KJ
Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase A activity and angiotensin III effects on [Ca2+]i along the rat nephron.
Hus-Citharel A; Gasc JM; Zini S; Marchetti J; Roques B; Corvol P; Llorens-Cortes C
Kidney Int; 1999 Sep; 56(3):850-9. PubMed ID: 10469354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
